about us

 

Randall Ribaudo, Ph.D., Partner, President, CEO



Human Workflows LLC co-founder Dr. Randall Ribaudo has over twenty years of experience in the Scientific Research and biotechnology field. Dr. Ribaudo co-founded Human Workflows after more than five years at Celera Genomics. During his time at Celera, Dr. Ribaudo has acted as a liaison between Celera and the pharmaceutical, biotechnology and academic communities, served as product manager responsible for developing support products for the Proteomics Groups mass spectrometry software, led the iScience Task Force to define strategic directions for sister company Applied Biosystems, advised on product development for the Celera Discovery System and enterprise solutions for information integration, and worked as a Manager of Strategic Solutions in the Informatics business.

Prior to Celera, Dr. Ribaudo worked at the biotechnology and bioinformatics company Molecular Applications Group. MAG developed pioneering bioinformatics solutions for molecular modeling, information integration, gene expression analysis, and protein function prediction. While at MAG, Dr. Ribaudo was responsible for presenting the revolutionary capabilities of MAG's products to representatives in the pharmaceutical, biotechnology and academic communities.

In 1999, when Celera Genomics acquired the Protein Function Prediction assets of Molecular Applications Group, Dr. Ribaudo joined their staff.

Dr. Ribaudo also has extensive experience in the academic biological life sciences arena as well. After receiving a Ph.D. in Immunology at the University of Connecticut, Dr. Ribaudo joined the Laboratory of Immunology, NIAID at the National Institutes of Health where he studied the molecular basis of antigen presentation. Dr. Ribaudo then accepted a position in the National Cancer Institute in the Laboratory of Immune Cell Biology as a Principal Investigator where he developed his own research program studying the immune response to viruses and tumors, leading a team of postdoctoral fellows, technicians, and University and High School students. His work at the National Cancer Institute led to the development of a novel technology to develop vaccines against tumors and viruses. Dr. Ribaudo holds patents for this technology which are now being further developed by private companies.

All of this experience has provided Dr. Ribaudo with tremendous insight into the rapidly exploding technological capabilities in areas of discovery research, information and data management, as well as a detailed understanding of the human workflows that are required to successfully implement those technological solutions.



Larry Petcovic, co-founder, Vice President for Communications



Bio for Larry Petcovic

1/1/2014

Larry started his career as a Health Physicist. He quickly recognized the importance of mastering communications and added a degree in applied behavioral sciences with continuing studies in the social neurosciences. He continues to consult as an Executive Communications Coach with Fortune 100 clients as well as startups. His experience in 360° performance coaching, behavioral based blended training, process improvement techniques, selling skills and leadership development provides an in-depth corporate understanding. Larry has served in Training and Human Resources VP positions in a variety of industries. Larry holds a BS in Chemistry, an MS from Rutgers University in Environmental Radiation Sciences, an MS from Johns Hopkins University in Applied Behavioral Sciences and additional graduate studies in Executive Development at George Washington University. 



Todd Pihl, Ph.D., co-founder, special advisor



Human Workflows LLC co-founder Dr. Todd Pihl has been in the scientific research and biotech fields for over fifteen years. Prior to co-founding Human Workflows, Dr. Pihl worked at Celera Genomics where he served in several roles including customer support, sales support, training, product management of software development and business development for the Informatics business unit. His main role at Celera was to train and guide customers to take full advantage of Celera’s informatics and bioinformatics products and to advise Celera’s engineering groups as to enhancements to Celera product offerings that more fully support customer’s workflows.

Dr. Pihl came to Celera from Bioveris Corp (formerly IGEN International) where he worked on applications utilizing electrochemiluminescence (ECL). Dr. Pihl’s work there focused both on developing assays using ECL as a detection method as well as working with engineers to develop next-generation ECL instruments.

Dr. Pihl has extensive experience as a scientist in the academic sector as well. After performing his graduate work at the Johns Hopkins University on the basic metabolism of bacteria from extreme environments , Dr. Pihl went on to further his research at Ohio State University where he developed a program to study gene regulation in methanogenic bacteria as well as supervised graduate and undergraduate students. Dr. Pihl conducted additional research at the National Institute for Diabetes, Digestive and Kidney diseases at the National Institutes of Health where he focused on small RNA molecules.

Dr. Pihl’s experience as both a developer and consumer of scientific software, data and tools has provided him with a deep understanding of how researchers really work, the types of challenges new products can face when trying to obtain customer acceptance and how to influence and counsel product development teams to maximize customer satisfaction.

 

ABOUT US    TERMS    PRIVACY POLICY    RESOURCES     FAQ   CONTACT